Skip to content

Physical Activity Monitoring Among BMT Patients

Physical Activity Monitoring Among Bone Marrow Transplant Patients: An Apple Watch Feasibility Study

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04474730
Enrollment
21
Registered
2020-07-17
Start date
2019-11-01
Completion date
2022-03-31
Last updated
2022-10-31

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Bone Marrow Transplantation

Keywords

Bone Marrow Transplantation, Mobile Health, Symptom Management, Physical Activity

Brief summary

This study aims to evaluate the feasibility of an apple watch-based application to promote physical activity among bone marrow transplant (BMT) patients.

Detailed description

The research objective is to test the feasibility of using an Apple Watch-based system with the capacity to monitor BMT patients' physical activity and other patient reported outcomes at an ongoing basis within the inpatient BMT setting at the University of Kentucky Markey Cancer Center (UKMCC). The central hypothesis in this project is that the Apple Watch-based system designed based on user-centered design principles and the proposed study method will yield high feasibility.

Interventions

DEVICEBMT Physical Activity app

This app sends reminders to patients, collect activity data from Apple Watch, and allow patients to submit symptoms.

OTHERWatch Only

A locked Apple Watch will be used to collect physical activity data from the Watch Only patients.

Sponsors

Ming-Yuan Chih
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
DEVICE_FEASIBILITY
Masking
SINGLE (Outcomes Assessor)

Intervention model description

In this study, we conduct a small randomized controlled trial to study the feasibility of an Apple Watch app developed to monitor bone marrow transplant patients' physical activities at their initial hospitalization.

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Design Phase: Post 100 days BMT patients, family caregivers and providers * Trial Phase: New BMT patients

Exclusion criteria

* under 18 years old; * can't communicate, read or write in English; * having any communicable infection or showing the signs of it, including coughing, fever, or rash; * and incapable of completing the assigned research activities.

Design outcomes

Primary

MeasureTime frameDescription
Feasibility - RecruitmentThe day of recruitmentRecruitment rate: the percentage of eligible patients who are enrolled
Feasibility - Study completionFrom enrollment to 30 day post transplant or at hospital dischargeStudy completion rate - The percentage of enrolled patients who completed the study
Feasibility - Usability30 day post transplant or at hospital dischargeA survey scale (User version - Mobile Application Rating Scale or uMARS) will be used to measure usability. uMARS scale score is calculated by averaging the likert scale answers, which range from 0 to 5. The uMARS score of 3.5 or higher is deemed to be acceptable usability.

Secondary

MeasureTime frameDescription
Physical Activity30 days post intervention or at hospital dischargeSteps

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026